MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
23 February 2023 - 8:30AM
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial
Results on March 8, 2023
NEWS RELEASEFEBRUARY 22,
2023, 4:30pm ET/ 22:30 CET
Company to Host Conference Call
with Live Q&A,
March 8,
2023 at
4:30pm
ET/
22:30
CET
IRVINE, CA, and HERSTAL,
BELGIUM – February 22, 2023 – MDxHealth SA (Nasdaq and
Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a
commercial-stage precision diagnostics company, today announced it
will release its financial results for the fourth quarter and full
year ended December 31, 2022, after market close on Wednesday,
March 8, 2023.
|
Title: |
Mdxhealth Presents Fourth Quarter and Full Year 2022 Financial
Results |
|
Speakers: |
Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief
Financial Officer |
|
Date: |
Wednesday, March 8, 2023 |
|
Time: |
4:30pm ET/ 22:30 CET |
|
Conference Call Dial-in
Details: |
United States: 1-877-407-9716Belgium: 0800 73904The Netherlands:
0800 023 4340United Kingdom: 0800 756 3429 |
|
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1600322&tp_key=c5695c9654 |
The webcast should be accessed 15 minutes prior to the
conference call start time. A replay of the webcast will be
available following the conclusion of the live call and will be
accessible on the Company’s website.
About mdxhealth®
Mdxhealth is a commercial-stage precision
diagnostics company that provides actionable molecular information
to personalize patient diagnosis and treatment. The Company’s tests
are based on proprietary genomic, epigenetic (methylation) and
other molecular technologies and assist physicians with the
diagnosis and prognosis of urologic cancers and other urologic
diseases. The Company’s U.S. headquarters and laboratory operations
are in Irvine, California, with additional laboratory operations in
Plano, Texas. European headquarters are in Herstal, Belgium, with
laboratory operations in Nijmegen, The Netherlands. For more
information, visit mdxhealth.com and follow us on social media at:
twitter.com/mdxhealth, facebook.com/mdxhealth and
linkedin.com/company/mdxhealth.
For more information:
|
mdxhealthinfo@mdxhealth.com |
|
| LifeSci
Advisors (IR & PR)US: +1 949 271
9223ir@mdxhealth.com |
|
NOTE: The mdxhealth logo,
mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate
Score, GPS and Monitor mdx are trademarks or registered trademarks
of MDxHealth SA. All other trademarks and service marks are the
property of their respective owners.
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From Jan 2025 to Feb 2025
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From Feb 2024 to Feb 2025
